Patent Assignment
Reel/Frame 075420/0453
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENTS AT R/F 41939/0487, 46591/0544 AND 53940/0001
Recorded: 2026-04-15
Received: 2026-04-15
Pages: 12
Assignor
MIDCAP FINANCIAL TRUST
Executed: 2023-04-04
Assignee
TERSERA THERAPEUTICS LLC,
520 LAKE COOK ROAD, DEERFIELD, IL, 60015, UNITED STATES
Covered Applications
(41)
SOLID DOSAGE FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOATE
App. No. 16/688,658
→
PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE COMPOUNDS
App. No. 15/043,129
→
PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE COMPOUNDS
App. No. 15/012,422
→
HYDROCHLORIDE SALTS OF 8-[1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXYMETHYL]-8-PHENYL-1,7-DIAZASPIRO[4,5]DECAN-2-ONE AND PREPARATION PROCESS THEREFOR
App. No. 14/683,871
→
TABLET FORMULATIONS CONTAINING 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE SALTS AND TABLETS MADE THEREFROM
App. No. 14/540,635
→
NK1 ANTAGONISTS
App. No. 14/341,097
→
Process and Intermediates for the Synthesis of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds
App. No. 14/043,210
→
PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE COMPOUNDS
App. No. 14/039,367
→
PHARMACEUTICAL FORMULATIONS: SALTS OF 8-[1-3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXYMETHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND TREATMENT METHODS USING THE SAME
App. No. 13/847,242
→
NK1 ANTAGONISTS
App. No. 13/625,799
→
SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE
App. No. 13/486,103
→
TRYPTOPHAN HYDROXYLASE INHIBITORS
App. No. 13/290,261
→
SOLID FORMS OF (S)-2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOIC ACID
App. No. 13/288,366
→
PHARMACEUTICAL FORMULATIONS:SALTS OF 8-[1-3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXYMETHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND TREATMENT METHODS USING THE SAME
App. No. 13/184,926
→
4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds and Methods of Their Use
App. No. 13/162,989
→
METHODS OF PREPARING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS
App. No. 13/160,678
→
COMPOUNDS USEFUL IN THE PREPARATION OF TRYPTOPHAN HYDRROXYLASE INHIBITORS
App. No. 13/024,469
→
METHODS OF TREATING PULMONARY HYPERTENSION
App. No. 13/006,592
→
NK1 ANTAGONISTS
App. No. 12/967,132
→
INTRAVENOUS FORMULATIONS OF NEUROKININ-1 ANTAGONISTS
App. No. 12/855,889
→
METHODS OF USING 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS
App. No. 12/754,341
→
MULTICYCLIC AMINO ACID DERIVATIVES AND METHODS OF THEIR USE
App. No. 12/750,278
→
1-PHENYL-1H-PYRAZOLE-BASED COMPOUNDS
App. No. 12/732,311
→
PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE COMPOUNDS
App. No. 12/531,859
→
HYDROCHLORIDE SALTS OF 8-[{1-(3,5-BIS-TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND PREPARATION PROCESS THEREFOR
App. No. 12/614,108
→
PHARMACEUTICAL FORMULATIONS: SALTS OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND TREATMENT METHODS USING THE SAME
App. No. 12/487,263
→
4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS AND METHODS OF THEIR USE
App. No. 12/468,974
→
PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLALANINES
App. No. 12/257,558
→
SOLID FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)-PYRIMIDIN-4-YL)PHENYL)PROPANOATE AND METHODS OF THEIR USE
App. No. 12/237,455
→
METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION AND RELATED DISEASES AND DISORDERS
App. No. 12/169,815
→
4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS AND METHODS OF THEIR USE
App. No. 11/954,000
→
AUTOMATICALLY OPERABLE SAFETY SHIELD SYSTEM FOR SYRINGES
App. No. 11/740,598
→
HYDROCHLORIDE SALTS OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY)-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND PREPARATION PROCESS THEREFOR
App. No. 11/732,548
→
PHARMACEUTICAL FORMULATIONS: SALTS OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND TREATMENT METHODS USING THE SAME
App. No. 11/732,663
→
PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLALANINES
App. No. 11/647,517
→
MULTICYCLIC AMINO ACID DERIVATIVES AND METHODS OF THEIR USE
App. No. 11/638,677
→
NK1 ANTAGONISTS
App. No. 11/358,827
→
AUTOMATICALLY OPERABLE SAFETY SHIELD SYSTEM FOR SYRINGES
App. No. 10/815,014
→
NK 1 ANTAGONISTS
App. No. 10/321,687
→
INJECTION DEVICE WITH PULL OFF STRIP
App. No. 29/154,724
→
AUTOMATICALLY OPERABLE SAFETY SHIELD SYSTEM FOR SYRINGES
App. No. 09/936,859
→